There is a 15-minute delay in the prices. To check out the live prices, log in to your Ventura account or open one today.
| Orders | Qty | Bid |
|---|---|---|
| 1 | 15 | 622.1 |
| 1 | 38 | 617 |
| 1 | 200 | 614.9 |
| 1 | 10 | 614.2 |
| 1 | 10 | 613.25 |
| Ask | Qty | Orders |
|---|---|---|
| 623 | 5 | 93 |
| 624 | 1 | 60 |
| 624.5 | 1 | 1 |
| 634.45 | 1 | 4 |
| 634.7 | 1 | 50 |
Annual Revenue,rose 22.13%, in the last year to ₹3,067 Cr. Its sector's average revenue growth for the last fiscal year was 16.32%.Annual Net Profit,rose 23.97% in the last year to ₹384.5 Cr. Its sector's average net profit growth for the last fiscal year was 90.21%.Quarterly Revenue,rose 29.17% YoY to ₹1,002.9 Cr. Its sector's average revenue growth YoY for the quarter was 20.47%.
Krishna Institute of Medical Sciences Limited (KIMS) is among India’s largest corporate healthcare providers, operating under the ‘KIMS Hospitals’ brand across South and West India. The Group’s integrated network offers a comprehensive range of multi‑disciplinary services, with a focus on affordable tertiary and quaternary care delivered through hospitals equipped with advanced clinical infrastructure . The Company, domiciled in India with its registered office in Secunderabad, Telangana, prepares standalone and consolidated financial statements and is listed on both BSE and NSE .
KIMS began with a single hospital and has grown steadily through strategic expansion and acquisitions, building a reputation for clinical depth supported by skilled professionals and strong patient‑centric systems . As of March 31, 2025, the Company had 13 subsidiaries (including those yet to commence operations) .
Key milestones include its stock market listing on June 28, 2021, and a sub‑division of equity shares from face value Rs 10 to Rs 2, approved on August 29, 2024, with a record date of September 13, 2024 .
– Dr. Bhaskara Rao Bollineni – Chairman & Managing Director
– Dr. Abhinay Bollineni – Director & Chief Executive Officer
– Sachin Ashok Salvi – Chief Financial Officer
– J R Nagajayanthi – Company Secretary & Compliance Officer
– Dandamudi Anitha – Whole‑time Director
– Share split: Equity shares were sub‑divided from face value Rs 10 each to Rs 2 each, as approved on August 29, 2024; the Company fixed September 13, 2024 as the record date .
– Acquisitions: The Company acquired Meda Institute of Podiatry Private Limited with effect from June 11, 2024, and Chalasani Hospitals Private Limited with effect from August 31, 2024 .
– Expansion pipeline: Beds are to be added shortly in cities including Mumbai, Bangalore and Bhubaneswar, as well as regions in Telangana and Andhra Pradesh; cities have been identified for expansion in FY 2025 .
– Network structure: KIMS continued to operate as a single reportable segment—medical and healthcare services—under its business model .
KIMS provides multi‑disciplinary medical and healthcare services, with emphasis on tertiary and quaternary care delivered through an integrated hospital network in South and West India
The Company has a robust footprint across South and West India, with hospitals tailored to regional healthcare needs .
As of March 31, 2025, KIMS had 13 subsidiaries, including subsidiaries that are yet to commence operations .
KIMS completed a share split (face value Rs 10 to Rs 2) effective with record date September 13, 2024, and acquired Meda Institute of Podiatry Private Limited and Chalasani Hospitals Private Limited during the year .
Yes, the Company is listed on BSE and NSE; the listing date was June 28, 2021
